Ewa Klamerus

939 total citations
9 papers, 603 citations indexed

About

Ewa Klamerus is a scholar working on Pharmacology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ewa Klamerus has authored 9 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 7 papers in Psychiatry and Mental health and 1 paper in Cellular and Molecular Neuroscience. Recurrent topics in Ewa Klamerus's work include Cannabis and Cannabinoid Research (7 papers), Schizophrenia research and treatment (7 papers) and Bipolar Disorder and Treatment (6 papers). Ewa Klamerus is often cited by papers focused on Cannabis and Cannabinoid Research (7 papers), Schizophrenia research and treatment (7 papers) and Bipolar Disorder and Treatment (6 papers). Ewa Klamerus collaborates with scholars based in United Kingdom, Italy and Netherlands. Ewa Klamerus's co-authors include Sagnik Bhattacharyya, Enrico Foglia, Tabea Schoeler, Robin Murray, Natalia Petros, Marta Di Forti, A. Carlo Altamura, G. Camuri, Anna M. Monk and Musa Sami and has published in prestigious journals such as The British Journal of Psychiatry, Psychological Medicine and Psychiatry Research.

In The Last Decade

Ewa Klamerus

9 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ewa Klamerus United Kingdom 8 452 352 111 99 93 9 603
Enrico Foglia United Kingdom 9 452 1.0× 357 1.0× 111 1.0× 106 1.1× 95 1.0× 9 649
Arianna Marconi Italy 4 424 0.9× 264 0.8× 105 0.9× 117 1.2× 113 1.2× 5 614
Willemijn A. van Gastel Netherlands 11 358 0.8× 205 0.6× 113 1.0× 141 1.4× 59 0.6× 15 519
Musa Sami United Kingdom 9 285 0.6× 223 0.6× 82 0.7× 76 0.8× 57 0.6× 24 461
Alain Dervaux France 13 152 0.3× 328 0.9× 114 1.0× 200 2.0× 39 0.4× 64 662
Eline Borger Rognli Norway 14 116 0.3× 252 0.7× 157 1.4× 151 1.5× 51 0.5× 32 552
F. Sorbara France 8 191 0.4× 316 0.9× 61 0.5× 87 0.9× 31 0.3× 9 427
Elizabeth Appiah‐Kusi United Kingdom 11 271 0.6× 198 0.6× 96 0.9× 157 1.6× 25 0.3× 21 501
Cale Basaraba United States 12 177 0.4× 90 0.3× 111 1.0× 162 1.6× 53 0.6× 37 488
Helena Vorma Finland 9 110 0.2× 187 0.5× 146 1.3× 69 0.7× 37 0.4× 24 431

Countries citing papers authored by Ewa Klamerus

Since Specialization
Citations

This map shows the geographic impact of Ewa Klamerus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa Klamerus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa Klamerus more than expected).

Fields of papers citing papers by Ewa Klamerus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewa Klamerus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa Klamerus. The network helps show where Ewa Klamerus may publish in the future.

Co-authorship network of co-authors of Ewa Klamerus

This figure shows the co-authorship network connecting the top 25 collaborators of Ewa Klamerus. A scholar is included among the top collaborators of Ewa Klamerus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewa Klamerus. Ewa Klamerus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Appiah‐Kusi, Elizabeth, R.F. Wilson, Marco Colizzi, et al.. (2019). Childhood trauma and being at-risk for psychosis are associated with higher peripheral endocannabinoids. Psychological Medicine. 50(11). 1862–1871. 15 indexed citations
2.
Edmonds, C. J., et al.. (2019). At what stage in the drinking process does drinking water affect attention and memory? Effects of mouth rinsing and mouth drying in adults. Psychological Research. 85(1). 214–222. 2 indexed citations
3.
Schoeler, Tabea, Natalia Petros, Marta Di Forti, et al.. (2017). Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis. The Lancet Psychiatry. 4(8). 627–633. 95 indexed citations
4.
Schoeler, Tabea, Natalia Petros, Marta Di Forti, et al.. (2017). Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis. Psychiatry Research. 255. 36–41. 19 indexed citations
5.
Foglia, Enrico, Tabea Schoeler, Ewa Klamerus, Kevin Morgan, & Sagnik Bhattacharyya. (2017). Cannabis use and adherence to antipsychotic medication: a systematic review and meta-analysis. Psychological Medicine. 47(10). 1691–1705. 48 indexed citations
6.
Petros, Natalia, Enrico Foglia, Ewa Klamerus, et al.. (2016). Impact of childhood trauma on risk of relapse requiring psychiatric hospital admission for psychosis. The British Journal of Psychiatry. 209(2). 169–170. 10 indexed citations
7.
Schoeler, Tabea, Natalia Petros, Marta Di Forti, et al.. (2016). Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study. The Lancet Psychiatry. 3(10). 947–953. 117 indexed citations
8.
Schoeler, Tabea, Anna M. Monk, Musa Sami, et al.. (2016). Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis. The Lancet Psychiatry. 3(3). 215–225. 222 indexed citations
9.
Schoeler, Tabea, Natalia Petros, Marta Di Forti, et al.. (2016). Association Between Continued Cannabis Use and Risk of Relapse in First-Episode Psychosis. JAMA Psychiatry. 73(11). 1173–1173. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Enrico Foglia Breakdown of academic impact, for papers by Arianna Marconi Breakdown of academic impact, for papers by Willemijn A. van Gastel Breakdown of academic impact, for papers by Musa Sami Breakdown of academic impact, for papers by Alain Dervaux Breakdown of academic impact, for papers by Eline Borger Rognli Breakdown of academic impact, for papers by F. Sorbara Breakdown of academic impact, for papers by Elizabeth Appiah‐Kusi Breakdown of academic impact, for papers by Cale Basaraba Breakdown of academic impact, for papers by Helena Vorma
Rankless by CCL
2026